San Francisco-based Bunkerhill Health raised $55 million in Series B funding July 16 to expand its Carebricks agentic AI platform — bringing total funding to $55 million across its seed, Series A and Series B rounds, according to a news release shared with Becker’s. Khosla Ventures led the round, with participation from Sequoia Capital, Felicis, Optum Ventures and Y Combinator.
Carebricks allows health systems to build and deploy AI agents across clinical, operational, and administrative workflows without relying on vendor-built tools, the release said. Current partners include Cleveland Clinic, Salt Lake City-based Intermountain Health, and the University of Texas Medical Branch in Galveston.
UTMB has more than 20 agents running on the platform. In its first month, a coronary calcium detection agent flagged a patient at imminent cardiac risk; he subsequently underwent a triple bypass. A nephrology triage agent cut average specialist wait times by more than 50%. A lung nodule agent resolved urgent incidental CT findings 80% faster and doubled guideline-concordant follow-up care, according to the release.
“We believe AI agents can help them turn more of those ideas into reality,” said Nishith Khandwala, co-founder and CEO of Bunkerhill Health. Peter McCaffrey, MD, chief AI officer at UTMB, credited the platform with delivering “tremendous impact on patient care” across clinical, operational, and administrative functions.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
